🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-09
Trial ID
NCT00014352
Treatments Being Tested
Italian multicenter study, will enroll \~566 pts with oligometastatic hormo...
Status
Recruiting
Location
European Institute of Oncology
Start Date
2023-03-01
Trial ID
NCT05649943
Treatments Being Tested
In this observational study, participants receive darolutamide: a treatment...
Status
Recruiting
Location
Many locations
Start Date
2026-07-31
Trial ID
NCT07538843
Treatments Being Tested
This study aims to predefine the threshold FSH doses during the early folli...
Status
Unknown
Location
Bagcilar Training and Research Hospital
Start Date
2014-12
Trial ID
NCT02329483
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Unknown
Location
Cancer Research UK at Cambridge Research Institute
Start Date
2008-09
Trial ID
NCT00967954
This phase II trial studies how well docetaxel or abiraterone acetate work ...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2019-02-08
Trial ID
NCT03827473
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihor...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2000-04
Trial ID
NCT00684905
Polycystic ovary syndrome (PCOS) affects 10% of all women, and it usually c...
Status
Unknown
Location
Royal Collage Of Surgeons
Start Date
2023-01-01
Trial ID
NCT05647356
Treatments Being Tested
This research study investigates whether male-level exogenous androgens inh...
Status
Terminated
Location
University of California San Diego
Start Date
2025-02-26
Trial ID
NCT06450405
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested